Author publication year | Intervention included (no.) | Male: Female | Age (years) | n. trigeminal deficit % | n. facial deficit (%)† | Useful hearing (%)‡ | Tumour size§ (mean mm) | Previous treatment (%) |
---|---|---|---|---|---|---|---|---|
Pollock 200610 | MS: 36 RS: 46 | 19:17 27:19 | 48 54 | 0 0 | 0 0 | 61 65 | 14 12 | No No |
Myrseth 200911 | MS: 28 RS: 60 | 12:16 36:24* | 53 58 | ? ? | 0 0 | 44 42 | 18 16 | No No |
Pollock 199512 | MS: 40 RS: 47 | 18:22 23:24 | 51 62* | 10 6 | 5 2 | 12 4 | >20 mm: 18% >20 mm: 29% | No No |
Myrseth 200515 | MS: 86 RS: 103 | ? ? | 50 60* | 20 12 | 1 1 | 2 10 | >20 mm: 32% >20 mm: 17% | No No |
Regis 200214 | MS: 110 RS: 100 | M 35% M 46% | 52 61 | 55 20 | ? 2 | ? 49 | KoosIII: 55%§ KoosIII: 34% | No No |
Karpinos 200213 | MS: 23 RS: 73 | 6:17 23:50 | 45 62* | 30 17 | 26 10 | 30 24 | >40 mm: 17* >40 mm: 3% | 26 14 |
MS: microsurgery, RS: radiosurgery.
*Significant (p<0.05).
†Percentage preserved, House-Brackmann grade 1–2.
‡Useful hearing: AAO-HNS class A–B or Gardner–Robertson grade I–II.
§KoosIII: tumour occupying the cerebellopontine cistern without brainstem displacement.